WRF
PCRX icon

Waddell & Reed Financial’s Pacira BioSciences PCRX Stock Holding History

Waddell & Reed Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$9.1M Buy
+129,880
New +$9.28M 0.02% 409
2017
Q4 		– Sell
-815,666
Closed -$30.6M – 550
2017
Q3 		$30.6M Buy
815,666
+100
+0% +$4.02K 0.07% 286
2017
Q2 		$38.9M Buy
815,566
+89,915
+12% +$4.17M 0.09% 261
2017
Q1 		$33.1M Buy
725,651
+163,971
+29% +$7.09M 0.07% 287
2016
Q4 		$18.1M Buy
+561,680
New +$18.7M 0.04% 350

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return